FDA committee recommends approval for Viagra rivalBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7242.1094/b (Published 22 April 2000) Cite this as: BMJ 2000;320:1094
- Scott Gottlieb
- New York
A committee of specialists at the US Food and Drug Administration (FDA) has recommended that the administration proceed with the approval of a new oral formulation of the drug apomorphine (Uprima) to treat impotence. Doctors predict that it will compete strongly with the highly popular drug sildenafil (Viagra).
Placed under the tongue, the drug encourages erections by stimulating the release of dopamine, which mediates the cerebral role …